Per Odin

1 – 10 of 178

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/4ca69e68-ab7c-43c9-af83-34fa2b50cab4?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
…
17
18
next »

2025
Mark Levodopa–entacapone–carbidopa intestinal gel : Data from the Swedish national registry for Parkinson's disease
Öthman, Mezin ; Bergquist, Filip ; Odin, Per ^LU ; Scharfenort, Monica ^LU ; Johansson, Anders ; Markaki, Ioanna ; Svenningsson, Per ; Dizdar, Nil and Nyholm, Dag ^LU (2025) In European Journal of Neurology 32(1).
- Contribution to journal › Article
Mark Impulse control disorders in Parkinson’s disease : a national Swedish registry study on high-risk treatments and vulnerable patient groups
Wolfschlag, Mirjam ^LU ; Weber, Gustav Cedergren ^LU ; Weintraub, Daniel ; Odin, Per ^LU and Håkansson, Anders ^LU (2025) In Journal of Neurology, Neurosurgery and Psychiatry 96(3). p.265-271
- Contribution to journal › Article
Mark Drug-Induced Cognitive Impairment
Reimers, Arne ^LU ; Odin, Per ^LU and Ljung, Hanna ^LU (2025) In Drug Safety 48(4). p.339-361
- Contribution to journal › Scientific review
Mark Health-Related Quality of Life in Relation to the 5-2-1 Criteria in Parkinson's Disease in Sweden
Hjalte, Frida ; Gustafsson, Anna ; Samuelsson, Jenny ; Bergquist, Filip ; Johansson, Anders and Odin, Per ^LU (2025) In Movement Disorders Clinical Practice
- Contribution to journal › Article
Mark The device-aided intrajejunal delivery of levodopa–entacapone–carbidopa intestinal gel the treatment of Parkinson’s disease : overview of efficacy and safety
Popławska-Domaszewicz, Karolina ; Metta, Vinod ; Odin, Per ^LU and Chaudhuri, K. Ray (2025) In Expert Review of Medical Devices 22(6). p.533-544
- Contribution to journal › Scientific review
Mark Simultaneous Nonmotor Symptoms Do Not Affect General Validity but Interpretation of the Parkinson's Disease Motor Diary
Andersson, Hampus ; Bremer, Alexander ; Gandor, Florin ; Ebersbach, Georg ; Löhle, Matthias ; Odin, Per ^LU and Storch, Alexander (2025) In Movement Disorders Clinical Practice 12(7). p.979-984
- Contribution to journal › Article
Mark The association between non-motor symptoms and cost in Parkinson’s disease
Gustafsson, Anna ; Hjalte, Frida ; Norlin, Jenny ; Odin, Per ^LU and Hagell, Peter ^LU (2025) In Journal of Neurology 272(4).
- Contribution to journal › Article
Mark Conversion between NMSS and MDS-NMS in Parkinson's Disease
Garon, Michela ; Rojo-Albuin, José Manuel ; Chaudhuri, K. Ray ; Rizos, Alexandra ; Rodriguez-Blazquez, Carmen ; Mamikonyan, Eugenia ; Biundo, Roberta ; Schrag, Anette ; Weintraub, Daniel and Antonini, Angelo , et al. (2025) In Movement Disorders 40(5). p.813-820
- Contribution to journal › Article
Mark Managing impulse control and related behavioral disorders in Parkinson’s disease : where we are in 2025?
Rigon, Leonardo ; Fogliano, Carmelo ; Chaudhuri, K. Ray ; Poplawska-Domaszewicz, Karolina ; Falup-Pecurariu, Cristian ; Murasan, Iulia ; Wolfschlag, Mirjam ^LU ; Odin, Per ^LU and Antonini, Angelo (2025) In Expert Review of Neurotherapeutics 25(5). p.537-554
- Contribution to journal › Scientific review
Mark Balance and gait disorders in de novo Parkinson’s disease : support for early rehabilitation
Lindholm, Beata ^LU ; Hagell, Peter ^LU ; Odin, Per ^LU ; Hansson, Oskar ^LU ; Siennicki-Lantz, Arkadiusz ^LU ; Elmståhl, Sölve ^LU ; Dahlin, Lars ^LU and Franzén, Erika (2025) In Journal of Neurology 272.
- Contribution to journal › Article

« previous
1
2
3
4
…
17
18
next »